2 Stocks Set To 2x In 24 Months
It’s been a volatile stretch for the markets. Between trade tensions, economic jitters, and mixed signals from policymakers, investors have had no shortage of reasons to stay on edge. The S&P 500 has slipped into correction territory, down more than 10% from its highs thanks in part to uncertainty over tariffs and recession fears.
But for seasoned investors,
» Read more about: 2 Stocks Set To 2x In 24 Months »
Read More
Market Commentary: When Will The The Market Top?
Believe it or not you’re about to get a very precise answer to the question when will the market top but, before the entree, a little appetizer.
As we enter year-end, the market has a lot of bullish forces driving it higher, and should continue to support the markets into the new year.
» Read more about: Market Commentary: When Will The The Market Top? »
Read More
Down 30%, Is It Time To Buy This Pharma Giant?
Bristol Myers Squibb (BMY) poses something of a conundrum to investors at the moment. On the one hand, the share price has dramatically underperformed the market, leading to concerns that further declines are on the horizon. And on the other hand, the valuation is starting to look really attractive to bargain hunters.
So,
» Read more about: Down 30%, Is It Time To Buy This Pharma Giant? »
Read More
1 Undervalued Healthcare Stock Flying Under The Radar
Molina Healthcare is not widely known among investors but that may be about to change following 15 quarters straight of year-over-year revenue growth and a member base that has grown to approximately 5.2 million across 20 states as of the most recent quarter.
Strategic moves like acquiring My Choice Wisconsin,
» Read more about: 1 Undervalued Healthcare Stock Flying Under The Radar »
Read More
Can a Bitcoin ETF 30x Your Money?
If you’re bullish on Bitcoin but want more than just price appreciation, the MSTY ETF might be the most interesting option on the table.
MSTY (YieldMax MSTR Option Income Strategy ETF) is a covered call fund on MicroStrategy, a company whose stock is effectively a leveraged bet on Bitcoin.
Since launching in 2024,
» Read more about: Can a Bitcoin ETF 30x Your Money? »
Read MoreThe Burst
Is Michael Saylor’s Bet Crazy: Bull vs Bear
Microstrategy (NASDAQ:MSTR) and its CEO Michael Saylor are in large part confounding valuation experts worldwide.
The traditional method of valuing a company goes something like this. Analyze the cash flows a company will produce over its lifetime, discount them back to present day, sum them up and arrive at a fair market valuation for the company.
» Read more about: Is Michael Saylor’s Bet Crazy: Bull vs Bear »
Read MoreThe Spotlight
Spotlight: 8 Analysts Just Upped Guidance On This Coffee Giant
Starbucks, a name synonymous with coffee, has grown beyond a mere chain of coffee shops to become a global icon in the beverage industry.
Unlike your regular run-of-the-mill local coffee shop, Starbucks has scaled its operations globally, transcending cultural and geographical boundaries. Its global footprint, though, has created its own set of challenges involving complex logistics like supply chain management,
» Read more about: Spotlight: 8 Analysts Just Upped Guidance On This Coffee Giant »
Read MoreThe Daily
The taxability of Social Security in 2025 | Paul Pahoresky
Much discussion has taken place this past year regarding the taxability of Social Security.
Several tax law changes that were enacted in 2025 under the One Big Beautiful Bill impact the overall taxability of Social Security. However, one of the most common surprises I see at tax time is this: a client assumes Social Security is “tax-free,” and then their return says otherwise.
» Read more about: The taxability of Social Security in 2025 | Paul Pahoresky »